| CENTER ID: | AcbyA.19027.a |
| ORGANISM: | Acinetobacter baylyi ATCC 33305 / BD413 / ADP1 |
| ASSOCIATED DISEASE: | |
| CURRENT STATUS: | cloned |
| COMMUNITY REQUEST: | True |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
unclassified |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| AcbyA.19027.a.B4.GE42195 | arabinose-binding domain | 19 | 213 | ||
| AcbyA.19027.a.B3.GE42194 | HTH-type | 243 | 348 | ||
| AcbyA.19027.a.B2.GE42193 | ordered domain | 18 | 348 |
| RESOURCE | REFERENCE ID |
|---|---|
| UniProt: | Q6F8C0 |
| HARVESTED ON: | data unavailable |
| SEQUENCED ON: | 3/1/2018 |
| EXPECTED MW: | 24kDa |
| OBSERVED MW: | 19kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Low Expression |
| SOLUBLE EXPRESSION LEVEL | No Expression |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 100 |
| PERCENT COVERAGE: | 100 |
| HARVESTED ON: | data unavailable |
| SEQUENCED ON: | 3/1/2018 |
| EXPECTED MW: | 13kDa |
| OBSERVED MW: | 25kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Moderate Expression |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 100 |
| PERCENT COVERAGE: | 100 |
| HARVESTED ON: | data unavailable |
| SEQUENCED ON: | 3/1/2018 |
| EXPECTED MW: | 39kDa |
| OBSERVED MW: | 19kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Moderate Expression |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 99 |
| PERCENT COVERAGE: | 100 |